Myrexis, Inc. (MYRX)

OTCMKTS · Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
At close: Feb 27, 2026
-91.43%
Market Cap 20.69K
Revenue (ttm) n/a
Net Income (ttm) -11.62M
Shares Out 34.48M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 818
Average Volume 6,312
Open 0.0006
Previous Close 0.0005
Day's Range 0.0006 - 0.0006
52-Week Range 0.0001 - 0.0070
Beta 3.97
RSI 42.67
Earnings Date n/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
CEO Jonathan Couchman
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MYRX
Full Company Profile

Financial Performance

News

There is no news available yet.